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In 1984, the first heart transplant carried out in Catalonia was performed at Hospital 
de la Santa Creu i Sant Pau. It was also the first successful heart transplant carried 
out in Spain. A few years later, in 1991, the Hospital Universitari de Bellvitge began 
working in this field, and was followed by the Hospital Clínic i Provincial de Barcelona 
in 1998. The Hospital Maternoinfantil Vall d’Hebron was authorized to perform heart 
and heart-lung transplants in 2006 for children and adolescents.  
 
The Heart Transplant Registry was created in 1993 and contains data on the 
transplants done in Catalonia since 1984. The data on transplants carried out in the 
1984-1993 period were gathered retrospectively, but, since 1994, the registry has 
systematically gathered data as they have become available.  
 
Publishing the registry is one of the objectives of OCATT, as is managing the data of 
the Registry Advisory Committee, which responds to the information requirements on 
planning, resource management and the purchase of services of the Catalan Health 
Service and the Ministry of Health. The registry is also an information source that is 
accessible to external users, such as healthcare professionals, and responds to the 
needs of other sectors. In all cases, processing of and access to data is subject to 
regulations in force on the protection of personal data.  
 
The main aim of this report is to provide information about the activity and 
characteristics of the heart transplants carried out in Catalonia in 2014, and to 
describe the evolution of the transplants carried out since 1984. This information is 
made available to professionals who are directly involved in this treatment, as well as 
members of the public administration working in the area of healthcare.   
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Some Remarks on Methodology 
 
This report describes the evolution of heart transplants in Catalonia and analyses the 
characteristics of receivers, donors and transplants, as well as the results obtained.  
 
The Kaplan-Meier method was used to calculate the patient survival rate (time before 
death). The level of statistical significance of the different curves was evaluated using 
the Log-rank test. The survival curves break off when the number of cases fell below 
10.  
 
The probability of receiving a transplantation was calculated bearing in mind the 
competitive risk model with three events of interest: transplantation, death and 
removal from the waiting list.  
 
 
Description of indicators:  
 
Annual transplant rate  
The total number of heart transplants carried out during the year at authorized 
centres, regardless of the place of residence of the receiver, compared with the 
population of Catalonia (census of 1991, 1996 and, starting in 1997, annual census 
updates. National Statistics Institute). Expressed per million inhabitants (pmi).  
 
Mortality rate at one month  
Percentage of deaths occurring during the 31 days following the heart transplant. 
 
Mortality rate at three months 
Percentage of deaths occurring during the 90 days following the heart transplant. 
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Evolution of Heart Transplants 
 
In the 1984-2014 period in Catalonia, 1198 heart transplants were performed: 1177 
first transplants and 21 retransplants. These transplants were carried out on 1179 
patients; two patients received the first transplant outside Catalonia.  
1,3% (15) of the transplants were combined with another organ (Table 1).  
 
Table 1. Number of combined transplants. 1984-2014 
  year activity init n 
Heart – pancreas  1988 1 
Heart – kidney 1999 10 
Heart – lung  2006 1 
Heart – liver  2008 3 
Total combined transplants  15 
 
 
The annual evolution of the number of heart transplants has varied over the years, 
showing upward trends in 1992 and 1997 (years in which new centres began activity) 
and until 2000, when the first changes in evolution were registered. In 2014, 56 
transplants were performed (Figure 1).   
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Because of these changes in trend, the annual rate of heart transplants was also 
affected and showed a clear upward trend in the 1992-2000 period, but has declined 
since then. In 2014, the transplant rate was 7.4 per million inhabitants (Figure 1).  
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The annual heart transplant rate varies considerably between countries. Catalonia 
shows one of the highest rates of transplant activity (Figure 2). However, these data 
should be interpreted with caution, bearing in mind different factors that affect 
transplant activity in each country (the healthcare system, indication criteria, 
population structure, etc.).    
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Source: Newsletter Transplant. International Figures on Organ Donation and Transplantation - 2014. September 2015. Vol. 20  
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Recipient characteristics  
 
 Sex and age 
 
Of the 1177 patients who received transplants (first transplants) in the 1984-2014 
period, 919 (78.1%) were men and 258 (21.9%) were women. In 2014, 41 (74.5%) 
patients were men and 14 (25.5%) were women. 
 
The mean age of the patients who received their first heart transplant in the 1984-
2014 period was 51 (52 for men and 48 for women), the median age was 54 with the 
range being from age 3 months to 72 years (Figure 3).  
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Over the years, the mean age has increased, going from 48 in 1997 to 53 in 2014 
(Figure 4). In 2014, 2 transplants were performed on children under 16 years of age, 
which have reduced the mean age. Taking into account patients aged 16 or over, the 
mean age in 2014 was 55.    
 
The increase in mean age over the years is largely due to the gradual increase in 
transplants done on patients aged 50 or more.  
In 2014, 16.4% (9) of the patients who received their first transplantation were 
between 50 and 60 and 49.1% (27) were over 60. In 1997, these percentages were 
33.3% (15) and 20.0% (9), respectively (Figure 5).   
 
Globally, 65.5% of patients were 50 or over when they received their first heart 
transplant. In fact, 52.3% of all patients were men aged 50 or more. 
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Figure 4. Annual evolution of the mean age of patients receiving their first heart transplant. 
1992-2014   










Number of patients (first transplants) = 1067  
 
 
Figure 5. Annual evolution of the percentage of patients who received their first heart 
transplant, by age group. 1992-2014  
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 Place of residence    
 
91.0% (n = 1073) of patients receiving transplants were residents of Catalonia, 8.6% 
(n = 101) were residents of another part of Spain, and 0.4% (n = 5) were foreigners. 
In general, the patients who were not residents of Catalonia came from the Balearic 
Islands (n = 62) or the autonomous community of Aragon (n = 15).  
 
 
 Indications  
 
The diseases for which a heart transplant is indicated are arranged in four groups: 
dilated cardiomyopathy, ischemic cardiomyopathy, valvular cardiomyopathy and the 
“other” category, which includes restrictive cardiomyopathy, congenital 
cardiomyopathy and hypertrophic cardiomyopathy.  
 
Dilated cardiomyopathy and ischemic cardiomyopathy have been the two most 
common indications and represent 42.6% and 38.7%, respectively, of all the heart 
transplants carried out in Catalonia since 1984 (Figure 6). In the case of men, 45.5% 
of patients suffered from ischemic cardiomyopathy and 39.9% from dilated 
cardiomyopathy. In the case of women, the most common indication (51.9%) was 
dilated cardiomyopathy (Figure 7).  
 









Number of patients (first transplants) = 1177  
 
 
Table 2 provides a breakdown of the indications included in the “Other Indications” 
category.  
 
Catalan Heart Transplant Registry. 1984-2014 
 16










 Dilated cardiomyopathy  Ischemic cardiomyopathy





Number of patients (first transplants) = 1177  
 
 
Table 2. Indications included in the “Other Indications” category. 1984-2014 
  Men Women Global 
  n % n % n % 
Hypertrophic cardiomyopathy 19 (33,3%) 21 (36,2%) 40 (34,8%) 
Restrictive cardiomyopathy 19 (33,3%) 17 (29,3%) 36 (31,3%) 
Congenital disease 14 (24,6%) 15 (25,9%) 29 (25,2%) 
Arrhythmogenic right 
ventricular dysplasia 
4 (7,0%) 5 (8,6%) 9 (7,8%) 
Sarcoidosis 1 (1,8%) - 1 (0,9%) 
Total 57 (100%) 58 (100%) 115 (100%) 
 
 
In 2014, 43.6% (n = 24) of the patients with ischemic cardiomyopathy, 38.2% (n = 21) 
with dilated cardiomyopathy and 18.2% (n = 10) with other indications (three patients 
with restrictive cardiomyopathy, three with hypertrophic cardiomyopathy and four with 
congenital disease).  
The most common disease has changed over the years. Although dilated 
cardiomyopathy was the most frequent indication in the early years, the percentages 
of this disease are now much more similar to those of ischemic cardiomyopathy and 
in some years this indication was even the most frequent. At any rate, given the low 
number of transplants performed annually, it is difficult to assess the slight changes 
between one year and another (Figures 8 and 9).  
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Figure 8. Annual evolution of the number of patients who received their first heart transplant, 
by indication. 1992-2014 
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Figure 9. Annual evolution of the percentage of patients who received their first heart 
transplant, by indication. 1992-2014 
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In 2004, the registry started using a new system to classify indicated diseases so 
they could be accounted for more accurately. The most frequent indications in the 
years from 2004 to 2014 were idiopathic dilated cardiomyopathy, ischemic 
cardiomyopathy and valvular cardiomyopathy (Figure 10).  
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(1) 2 postpartum; 2 non-ischemic; 1 viral; 1 associated with muscular 
dystrophy; 1 Becker distrophy
(2) Restrictive and pulmonary hypertension secondary to schistosomiasis
(1)
(2)
Number of patients (first transplants) = 529  
 
 
The most frequent indication in patients younger than 50 years is dilated 
cardiomyopathy. In patients over 50 years, the percentage of patients with ischemic 
cardiomyopathy is slightly higher than dilated cardiomyopathy (Figure 11).  
 
Figure 11. Percentage of patients who received their first heart transplant, by indication and 
age group. 1984-2014 
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Statistically significant differences in mean age were observed between the four 
indications (p < 0.0001): the patients with ischemic cardiomyopathy or valvular 
cardiomyopathy were older than those who presented with dilated cardiomyopathy 
(Table 3). The differences between men and women when treated separately were 
also statistically significant (Table 4).  
 
Table 3. Mean and confidence interval of age, by indication. 1984-2014  
  n mean IC 95% range 
Dilated cardiomyopathy  501 49 47,5 – 50,2 0 – 72 
Ischemic cardiomyopathy 456 55 54,1 – 55,7 1 – 72 
Valvular cardiomyopathy 105 55 52,8 – 56,4 17 – 67 
Other forms of 
cardiomyopathy  
115 41 37,3 – 44,0 0 – 68 
Total  1.177 51 50,1 – 51,7 0 – 72 
 
 
Table 4. Mean and confidence interval of age, by indication and sex. 1984-2014 
    n mean IC 95% range 
Dilated 
cardiomyopathy 
Men  367 49 47,1 – 50,2 0 – 72 
Women 134 49 46,9 – 52,1 1 – 69 
Ischemic 
cardiomyopathy 
Men  418 55 54,3 – 55,9 1 – 72 
Women 38 53 50,1 – 55,7 34 – 69 
Valvular 
cardiomyopathy 
Men  77 54 51,7 – 56,1 17 – 67 
Women 28 57 53,2 – 59,9 28 – 65 
Other forms of 
cardiomyopathy 
Men  57 43 38,1 – 47,8 1 – 68 
Women 58 38 33,7 – 43,1 0 – 67 
Total 
Men  919 52 50,8 – 52,5 0 – 72 










 Sex and age 
 
Of the 1085 transplants carried out in the 1992-2014 period, 68.6% (n = 744) of the 
donors were men and 31.4% (n = 341) were women. In 2014, 62.5% (n = 35) were 
men and 37.5% (n = 21) were women. 
 
The mean age of the donor over the 1984-2014 period was 34, the median age was 
also 33 and the range was from some months to 64 years (in the 1992-2014 period, 
the mean age of the donor was 35 and the median was 35 too). The mean age has 
increased over the years, going from 25 in 1992 to 45 in 2014 (Figure 12).  
 
This increase has occurred because of older donors, given that in 2014, 51.8% of 
donors were age 50 and over, whereas there were no donors in this age group in the 
first years of the programme.  
 
Figure 12. Evolution of the mean age of the donor. 1992-2014 















 Mean age  0-18  19-34  35-49  >= 50 
Number of donors = 1085  
 
 
 Cause of death 
 
The most frequent cause of death of the donor was head trauma (HT), which 
represented 50.6% (n = 606) of all causes, followed by cerebrovascular accident 
(CVA) / stroke, which represented 39.5% (n = 473) (In the 1992-2014 period, these 
percentages were 48.8% and 41.2%, respectively).  
 
In keeping with the increase in the age of donors, the number of donors who died 
from CVA / stroke also increased (Figure 13). In 2014, 30.4% (n = 17) of donors died 
from head trauma and 58.9% (n = 33) from CVA / stroke.  
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Figure 13. Evolution of the cause of death of donor (%). 1992-2014  
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 Source of organs  
 
In the 1984-2014 period, 20.5% (n = 246) of the transplanted organs came from the 
same hospital where the transplant was carried out, 43.7% (n = 523) from other 
hospitals in Catalonia, and 35.8% (n = 429) from hospitals outside Catalonia. In 
2014, 16.1% (n = 9) of the organs came from the same hospital, 39.3% (n = 22) from 
Catalonia, and 44.6% (n = 25) from outside Catalonia (Figure 14).  
 
Figure 14. Annual evolution of the source of organs (%). 1992-2014  
Number of transplants = 1085
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Of the 1198 transplants carried out in the 1984-2014 period, 23.8% (285) were 
emergency. The evolution of the percentage of emergency transplants shows an 
upward trend (Figure 15).  
 
48.2% (27) of the transplants carried out in 2014 were emergency, which is a very 
similar percentage than in pervious years.  
 























































 Assistance device  
 
In keeping with the increase in emergency transplants, the number of patients who 
received a ventricular assist device prior to transplant also increased (Figure 16).  
In 2014, 77.8% (21) of the emergency transplanted patients received an assist 
device: 15 intraaortic balloon pump, 2 ECMO, 2 continuous flow device and 2 
pulsatile device.  
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Figure 16. Annual evolution of the ventricular assistance device in emergency transplants. 
1997-2014 
3 4 2 2 1 1 1 1
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 Ischemia time   
 
The mean ischemia time was 178 minutes. Bearing in mind the source of the organ, 
the differences observed were statistically significant (p < 0.0001). When the organ 
came from a hospital outside Catalonia, the mean ischemia time was 72 minutes 
longer than when the organ came from a hospital in Catalonia (Table 5).   
 
Table 5. Ischemia time, in minutes, in accordance with the source of the organ. 1984-2014 
  





(n = 245) (n = 520) (n = 426) (n = 1191) 
Mean 132 157 230 178 
Median 127,0 150 232 174 
Range 60 – 238 64 – 369 80 – 360 60 – 369 




 Immunosuppressors  
 
The distribution of immunosuppressors used in the first six weeks after transplant is 
shown in Figure 17. The overwhelming majority of transplant patients underwent 
induction immunosuppressive treatment and basiliximab was the drug used most.  
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A total of 21 of the 1142 heart transplants (1.8%) carried out in the 1984-2014 period 
have been retransplanted. Two of these patients received the first transplant outside 
Catalonia.  
 
The time between one transplantation and the other ranged from 1 day  to 13 years 1. 
The mean was 5 years (the median was 6 years). Specifically, 4 patients (21.1%) 
received a second transplant within the first week after receiving the first, 3 (15.8%) 
between the first week and three months after receiving the first transplant, and 12 
(63.2%) after the first year.  
 
Tables 6 and 7 show the main characteristics of the retransplants.  
 
Table 6. Characteristics of the patients who received a retransplantation, by the time elapsed 
since the first transplantation. 1984-2014   
  
0 - 3 months > 3 months 
(n = 7) (n = 12) 
Sex 
Men 5 (71.4%) 9 (75.0%) 
Women 2 (28.6%) 3 (25.0%) 
Age (years) 
Mean 44 37 
Median 42 39.5 
Range 35 – 63 15 – 59 
Indications 
Dilated cardiomyopathy 2 (28.6%) 9 (75.0%) 
Ischemic cardiomyopathy 3 (42.9%) 3 (25.0%) 
Valvular cardiomyopathy - - 
  
Other forms of 
cardiomyopathy  
2 (28.6%) - 
 
 
Of the 7 patients who received a retransplantation in the first three months after the 
first transplant, four had died (two by infection) at 31 December 2014. Of the 12 
patients who received a retransplantation after the third month, 10 had died at 31 
December 2014: 2 due to graft vascular disease, 2 due to primary dysfunction of the 
graft, 1 due to infection and 5 due to other causes.  
 
 
                                                
1 Taking into account the patients who received the transplant and retransplant in Catalonia. 
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Table 7. Characteristics of the donor and the transplantation (first transplant), by the time 
elapsed since the first transplantation. 1984-2014 
  
0 - 3 months > 3 months 
(n = 7) (n = 12) 
Donor age (years) 
Mean 20 26 
Median 23 22,5 
Range 11 – 25  14 – 49  
Cause of donor’s death  
HT 6 (85,7%) 9 (75,0%) 
CVA -  2 (16,7%) 
Other 1 (14,3%) 1 (8,3%) 
Ischemia time (minutes) 
Mean 139 168 
Median 115 148 









The survival rate of patients receiving a first heart transplant in Catalonia in the 1984-
2014 period was 87% in the first month, 78% in the first year, 72% in the third year, 
and 69% in the fifth year (Figure 18).  
 
Figure 18. Survival rate of patients receiving a heart transplant. 1984-2014  
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1st month 3rd month 1st year 3rd year 5th year 10th year 15th year 20th year




The survival rate percentages were very similar to those of the Spanish and 
international registries (Table 8).  
 
Table 8. Survival: Data comparing the Catalan (RTCC), Spanish (RETC)2 and international 
registries (ISHLT)3. 1984-2014  
  RTCC  RETC  ISHLT    
  (1984-2014) (1984-2014) (1982-6/2013) 
1st month 0,86 0,85 0,90 
1st year 0,77 0,76 0,82 
5th year 0,68 0,65 0,69 
10th year 0,55 0,52 0,52 
15th year 0,38 0,38 0,35 
 
The overall patient survival rate in the 1984-2014 period was affected by the 
characteristics of the transplants carried out in the first few years (low number of 
                                                
2 González-Vílchez F, et al. Registro Español de Trasplante Cardíaco. XXVI Informe Oficial 
de la Sección de Insuficiencia Cardíaca y Trasplante Cardíaco de la Sociedad Española de 
Cardiología (1984-2014). Rev Esp Cardiol. 2015.  
3 International Society for Heart and Lung Transplantation (available at: http://www.ishlt.org). 
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cases, learning period) and by the factors of the transplants carried out in 
subsequent years (the inclusion of older patients and patients with a more negative 
prognosis).  
 
The study by period was divided into four time intervals: 1984-1991, 1992-1996, 
1997-2001, 2002-2006 and 2007-2014. Statistically significant differences were 
observed between the five periods (p = 0.001), but not between the last four (Figure 
19).  
 
Figure 19. Survival rate of patients receiving a heart transplant, by period. 1984-2014 










  (n = 110) 
 1992-96
  (n = 167) 
 1997-01
  (n = 275) 
 2002-06
  (n = 240) 
 2007-14
  (n = 385)
1st month         0.66      0.89 0.87 0.89 0.90
1st year            0.56 0.77 0.80 0.82 0.80
3rd year  0.51 0.75 0.73 0.76 0.75
5th year 0.50 0.71 0.69 0.74 0.71





In order to gain a more up-to-date look at the results, survival rates were prepared 
with data on the transplants carried out since 1997. In the 1997-2014 period, the 
patient survival rate was 89% in the first month, 81% in the first year, 75% in the third 
year, 71% in the fifth year, and 58% in the tenth year.  
 
The long-term survival rate was slightly lower for men than women (Figure 20), 
though the differences were not statistically significant (p = 0.066). 
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Figure 20. Survival rate of patients receiving a heart transplant, by sex. 1997-2014  










  (n = 691)   
  Women
  (n = 209)   
Number of patients = 900
1st month 0.88      0.89
1st year 0.80 0.82
3rd year 0.73 0.81
5th year 0.69 0.78





Patients over the age of 60 have the lowest survival rate, with statistically significant 
differences (p = 0.030) (Figure 21). 
 
Figure 21. Survival rate of patients age 15 and older receiving their first heart transplant, by 
age group. 1997-2014 










  (n = 245)   
 50-54 y
  (n = 151)   
 55-59 y
  (n = 154)
 60-64 y
  (n = 198)
 65+ y
  (n = 121)
1st month 0.89      0.89 0.89 0.86 0.88
1st year 0.84 0.81 0.84 0.74 0.77
3rd year 0.78 0.73 0.79 0.70 0.67
5th year 0.75 0.69 0.76 0.66 0.65
10th year 0.63 0.55 0.63 0.52 0.47
Number of patients = 869
p = 0.030
p16-49 vs 60-64 = 0.009
p16-49 vs 65+ = 0.042
p55-59 vs 60-64 = 0.019
other comp. p > 0.05
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Bearing in mind the indicated disease, the patients with valvular cardiomyopathy 
showed a higher survival rate than patients with ischemic cardiomyopathy, who had 
the lowest survival rate (Figure 22). The differences between the four diagnostic 
groups were statistically significant (p = 0.015) and also the differences between the 
two most represented diagnostic categories (p = 0.005).  
 
Figure 22. Survival rate of patients receiving a heart transplant, by indication. 1997-2014  










(n = 356)   
 Ischemic
 (n = 363)   
 Valvular
 (n = 82)  
 Other
(n = 99)
Number of patients = 900
1st month 0.91 0.85 0.93 0.89
1st year 0.82 0.77 0.87 0.85
3rd year 0.77 0.69 0.83 0.79
5th year 0.74 0.67 0.77 0.74
10th year 0.64 0.50 0.60 0.58
p = 0.015
pDilated vs Ischemic = 0.005
pIschemic vs Valvular = 0.032




Figure 23. Survival rate of patients receiving a heart transplant, by ischemia time. 1997-2014 









 <= 4 hours
(n = 737)      
 > 4 hours 
 (n = 158)   
Firsts transplants = 895
p = 0.004
1st month 0.90      0.84
1st year 0.83 0.72
3rd year  0.76 0.67
5th year 0.73 0.65
10th year 0.59 0.50
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When the survival rate was analysed based on the time elapsed between the 
extraction of the organ and the time of the transplant, it was observed that the 
probability of survival was greater when the ischemia time was less than or equal to 
four hours (p = 0.004) (Figure 23).  
 
Figure 24. Survival rate of patients receiving a heart transplant, by emergency. 1997-2014 










(n = 221)      
 Elective 
 (n = 624)   
First transplants = 900
p = 0.008
1st month  0.85      0.90
1st year 0.73  0.84
3rd year 0.66  0.78
5th year 0.62  0.75




Figure 25. Survival rate of patients receiving a heart transplant, by emergency and ventricular 
assistance device. 1997-2014 










 (n = 639)   
 Emerg. - balloon 
 (n = 152)   
 Emerg. VAD *  
 (n = 52)   
 Emerg. without VA **
 (n = 42)   
p < 0,0001
pElec-Emer Balloon-Emer VAD < 0,0001
1st month 0.90 0.89 0.73 0.93
1st year 0.84 0.74 0.61 0.90
3rd year 0.78 0.69 0.54 0.77
5th year 0.75 0.64 0.54 0.69
10th year 0.60 0.53 *  *
First transplants  = 895
* Continuous flow and pulsatile device included
** Electrical storm  
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There are statistically significant differences (p = 0.008) in survival rates of patients 
depending on whether the transplant was an emergency or elective (Figure 24).  
 
Taking into account the different devices used in emergency transplants, the most 









Of the 1179 patients receiving a transplant in the 1984-2014 period, 587 (49.8%) had 
died at 31 December 2014, 584 (49.5%) remained alive, and monitoring could not be 
continued on 8 (0.7%).  
 
The most common causes of death were infection (21.6%), primary dysfunction of 
the graft (14.9%), neoplasm (13.8%) and graft vascular disease (10.4%). The first 
three causes alone accounted 50% of all deaths (Figure 26).  
 



















Number of deaths = 579 In eigth cases, the cause of death was unknown 
 
 
When the sex of the patient was considered, these four causes of death were the 
same, though the percentages for each sex varied (Figure 27).  
 
 
In 27.1% of cases, death occurred in the first month after transplantation (Figure 28) 
and the main cause of death was primary dysfunction of the graft (Figure 29).  
 
The mortality rate at one moth (31 days) is 14.1% (11.9% in 1997-2014 period). In 
2014, the mortality rate at one month was 5.4%, lower than the year before (Figure 
30).  
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Number of deaths = 579 In eigth cases, the cause of death was unknown 
 
 












 < 30 days  30 days
 1st year
 1st year 
 3rd year
 3rd year 
 5th year
 5th year 
 10th year
 > 10th year








Number of deaths = 587  
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Figure 29. Percentage of deaths by cause of death and time elapsed since the 
transplantation, patients who received a single heart transplant. 1984-2014 
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 Acute rejection  Graft vascular disease  Primary dysf. of graft  Infection  Neoplasm
 Sudden death  Cerebrovascular disease   Multiorganic failure   Other causes
Number of deaths = 566 In seven cases, the cause of death was unknown 
 
 
















































 Mortality rate at 1st month  
 Mortality rate at 3rd month
Mortality rate at 1st month, 1997-2014: 11,9%
Mortality rate at 3rd month, 1997-2014: 15,5%  
 
 
Mortality was analysed in terms of percentage (per 100 people/year) in relation to the 
period (year of death). The 1984-1991 period was clearly the one with the highest 
mortality rate (18.06%), whereas in subsequent periods the mortality rate was less 
than half the rate of the first period (1992-1996: 7.12%; 1997-2001: 6.25%; 2002-
2006: 5.45%; 2007-2014: 5.94%). Figure 31 shows the distribution of the cause of 
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death by period, and reflects the drop in mortality due to primary dysfunction of the 
graft and severe rejection.  
 
Figure 31. Distribution of the cause of death by period, year of death, as a percentage (per 
















Mortality per 100 people/year
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Waiting List  
 
The number of patients on the waiting list at the end of 2014 was upper than in 
previous years, going from 27 to 29 (Figure 32).   
 






















































 Annual number of transplants  Waiting list at 31/12
Source: Donor and Transplant Registry  
 
 
Figure 33. Mean number of days on the waiting list to receive a heart transplant. 2000-2014  








Mean number of days on waiting list
 Elective transplants  Emergency transplants
Source: Donor and Transplant Registry  
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In 2014, the mean number of days that a patient was on the waiting list for a heart 
transplant was 150; 202 days in elective transplants and 58 days in emergency 
transplants (Figure 33). 
 
In 2014, 76 patients were added to the waiting list. Of the patients taken off the list, 6 
were removed because their health improved, 2 worsened and one voluntary 
removal. The mortality rate of the patients on the waiting list was 6.7% (7). Because 
of the low number of cases in recent years, the major fluctuations observed should 
be evaluated with caution (Figure 34).  
 





































Mortality of patients on waiting list (%)
 % Death  % Death
 + Definitive exclusions
Source: Donor and Transplant Registry  
 
 
In the 2000-2014 period, the probability of receiving a heart transplant in the first six 
months on the waiting list was 62%; in the first year, it was 76% (Figure 35).  
 
When the probability of receiving a transplant was analysed bearing in mind the 
patient’s blood type, it was observed that for patients with blood type A, the 
probability (62% in the first six months and 74% in the first year) was slightly higher 
than patients with blood type O (59% in the first six months and 74% in the first year). 
Patients with blood type B and AB had higher probabilities, but these probabilities 
were unreliable due to the low number of cases (Figure 36).  
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Figure 35. Probability of receiving a heart transplant. 2000-2014 
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Source: Donor and Transplant Registry  
 
 
Figure 36. Probability of receiving a heart transplant, by blood type. 2000-2014 
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 A (n = 415)  B (n = 83)  AB (n = 34)  O (n = 389) p = 0.004
Source: Donor and Transplant Registry  
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Heart Transplants in Children  
 
Of the 1198 transplants carried out in Catalonia in the 1984-2014 period, 43 were 
performed on children under 16 years of age (42 first transplants and one 
retransplant). In 2014, 2 transplants were performed. 
 
Of the 42 patients who received heart transplants, 57.1% (24) were men and 42.9% 
(18) women. The mean age was 9 (median = 12, range = 3 month – 15 years), 
although 52.4% (22) of patients were 12-15 years. 
 
The two most frequent indications are dilated cardiomyopathy and congenital disease 
(Figure 37 and 38).  
 














Number of patients (first transplants) = 42  
 
 
Tables 9 and 10 show the characteristics of the donor and the transplants carried out 
on children.  
 
Of the 43 patients (under 16 years of age), one needed a retransplant and thirteen 
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Figure 38. Indications in patients receiving transplants as children (under 16 years of age) by 
age group. 1984-2014  
 < 2 
  (n = 11)
 2-11 
  (n = 9)
 12-15 








Percentage of patients (fists transplants)
 Dilated  Ischemic  Restrictive
 Hypertrophic  Congenital disease  Arrhythmogenic right ventricular dysplasia
Number of patients (first transplants) = 42  
 
Table 9. Characteristics of donors in patients receiving transplants as children (under 16 
years of age). 1984-2014 
Sex of donor      
Men 19 (44,2%) 
Women 23 (53,5%) 
Missing data 1 (2,3%) 
Donor age (years) 
Mean (± SD) 15 (±  12,8) 
Median 15 
Range 0 – 56 
Cause of donor’s death  
HT 21 (48,8%) 
CVA 5 (11,6%) 
Other 17 (39,5%) 
Source of organ  
Same hospital  8 (18,6%) 
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Table 10. Characteristics of transplants in patients receiving transplants as children (under 16 
years of age). 1984-2014 
Emergency     
Urgent 21 (48,8%) 
Elective 22 (51,2%) 
Ischemia time (minutes) 
Mean (± SD) 205 (±  57,7) 
Median 206 
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